[go: up one dir, main page]

GR1006881B - Αντιγηραντικες ιδιοτητες της κερκετινης, του 18(α) - γλυκυρετινικου οξεος της χεδεραγενινης και των παραγωγων τους - Google Patents

Αντιγηραντικες ιδιοτητες της κερκετινης, του 18(α) - γλυκυρετινικου οξεος της χεδεραγενινης και των παραγωγων τους

Info

Publication number
GR1006881B
GR1006881B GR20090100242A GR20090100242A GR1006881B GR 1006881 B GR1006881 B GR 1006881B GR 20090100242 A GR20090100242 A GR 20090100242A GR 20090100242 A GR20090100242 A GR 20090100242A GR 1006881 B GR1006881 B GR 1006881B
Authority
GR
Greece
Prior art keywords
ageing
hederagenin
quercetin
derivatives
propeties
Prior art date
Application number
GR20090100242A
Other languages
English (en)
Inventor
Ιωαννα Χηνου
Νικη Χονδρογιαννη
Ευσταθιος Γκονος
Original Assignee
Κορρες Α.Ε. Φυσικα Προϊοντα,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Κορρες Α.Ε. Φυσικα Προϊοντα, filed Critical Κορρες Α.Ε. Φυσικα Προϊοντα,
Priority to GR20090100242A priority Critical patent/GR1006881B/el
Priority to EP09006147.4A priority patent/EP2246037A3/en
Publication of GR1006881B publication Critical patent/GR1006881B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90219—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
    • G01N2333/90222—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3) in general
    • G01N2333/90225—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3) in general with a definite EC number (1.10.3.-)
    • G01N2333/90229—Catechol oxidase, i.e. Tyrosinase (1.10.3.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90245—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Η κερκετίνη, το 18α-γλυκυρετινικό οξύ, και ή η χεδεραγενίνη και ή τα παράγωγα της χρησιμοποιούνται ως αντιγηραντικοί και ή λευκαντικοί παράγοντες για τη φροντίδα της επιδερμίδας. Αποκαλύπτονται οι μέθοδοι δοκιμής των αντιγηραντικών και των λευκαντικών ιδιοτήτων των ενώσεων. 10061919 Η «ΑΛΥΣΙΔΑ ΧΙΟΝΙΟΥ-ΠΑΓΟΥ-ΛΑΣΠΗΣ» αποτελείται από σύστημα μικρών αλυσίδων (4) οι οποίες είναι προσαρμοσμένες σε δυο μεταλλικές λάμες (1) καθώς και σε ιμάντα σύσφιξης χαλάρωσης (2) πάνω στη ρόδα οχήματος. Στο μέσα μέρος της αλυσίδας υπάρχει επίσης προσαρμοσμένη επιφάνεια καουτσούκ (3) ή άλλου υλικού που δρα ως προστατευτικό του τροχού. Το «όλο» λειτουργεί ως αντιολισθητικό σύστημα.
GR20090100242A 2009-04-27 2009-04-27 Αντιγηραντικες ιδιοτητες της κερκετινης, του 18(α) - γλυκυρετινικου οξεος της χεδεραγενινης και των παραγωγων τους GR1006881B (el)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GR20090100242A GR1006881B (el) 2009-04-27 2009-04-27 Αντιγηραντικες ιδιοτητες της κερκετινης, του 18(α) - γλυκυρετινικου οξεος της χεδεραγενινης και των παραγωγων τους
EP09006147.4A EP2246037A3 (en) 2009-04-27 2009-05-06 Anti-aging and whitening properties of quercetin, 18a-glycyrrhetinic acid, hederagenin and its derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20090100242A GR1006881B (el) 2009-04-27 2009-04-27 Αντιγηραντικες ιδιοτητες της κερκετινης, του 18(α) - γλυκυρετινικου οξεος της χεδεραγενινης και των παραγωγων τους

Publications (1)

Publication Number Publication Date
GR1006881B true GR1006881B (el) 2010-07-13

Family

ID=42712648

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20090100242A GR1006881B (el) 2009-04-27 2009-04-27 Αντιγηραντικες ιδιοτητες της κερκετινης, του 18(α) - γλυκυρετινικου οξεος της χεδεραγενινης και των παραγωγων τους

Country Status (2)

Country Link
EP (1) EP2246037A3 (el)
GR (1) GR1006881B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY172154A (en) * 2012-08-29 2019-11-14 Biotropics Malaysia Berhad Composition for cognition and cosmetic purposes and use of said composition for preparing an agent
FR2997854B1 (fr) * 2012-11-15 2015-03-27 Rocher Yves Biolog Vegetale Utilisation d'un extrait de saba senegalensis dans une composition cosmetique anti-age
FR2997855B1 (fr) * 2012-11-15 2015-02-13 Rocher Yves Biolog Vegetale Utilisation d'un extrait de saba senegalensis dans une composition cosmetique apaisante et/ou uniformisant la couleur de la peau
CN110381917B (zh) * 2017-03-06 2023-10-31 默克专利股份有限公司 相容性溶质的用途
GR20180100094A (el) 2018-03-07 2019-10-16 Εθνικο Ιδρυμα Ερευνων Βιο-εμπνευσμενοι ενεργοποιητες του πρωτεασωματος με αντιγηραντικη δραση
EP4267090A1 (en) * 2020-12-23 2023-11-01 L V M H Recherche Cosmetic composition comprising an aqueous or an hydroalcoholic extract of peony

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180331B1 (en) * 2000-08-16 2008-07-09 Unilever N.V. Blends of isoflavones and flavones
JP4079443B2 (ja) * 2002-12-27 2008-04-23 ハンコック ファーム．カンパニー インコーポレーティッド 抗酸化及び老化抑制活性を有するハナズオウ抽出物及びそれを含む抗酸化、皮膚老化抑制及びシワ改善用化粧料組成物
US20080025930A1 (en) * 2006-07-31 2008-01-31 Hugo Corstjens Anti-aging Compositions Comprising Menyanthes Trifoliata Leaf Extracts and Methods of Use Thereof
FR2906139A1 (fr) * 2006-09-21 2008-03-28 Davines France Sarl Procede de traitement binaire cosmetique destine a lutter contre le vieillissement cutane et compositions pour sa mise en oeuvre
US8980344B2 (en) * 2007-10-01 2015-03-17 Dennis F. Gross Skin care products containing multiple enhancers

Also Published As

Publication number Publication date
EP2246037A2 (en) 2010-11-03
EP2246037A3 (en) 2015-09-09

Similar Documents

Publication Publication Date Title
MX2010007867A (es) Composiciones de limpieza personal concentradas.
JO3416B1 (ar) تركيبات مضادة للبكتيريا وطرق استخدامها
EP2513023A4 (en) COMPOSITIONS OF CIS-1,1,1,4,4,4-HEXAFLUOR-2-BUTENE AND ITS USES
MY155654A (en) Antibodies against human angiopoietin 2
WO2010111409A3 (en) Pluripotent stem cells
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
MX2011003473A (es) Composiciones para el cuidado bucal.
PH12012501355A1 (en) Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
SG10201408166QA (en) Probiotic microorganisms as active agents for enhancing the radiance of the skin’s complexion
MX379016B (es) Composiciones y metodos para tratar enfermedad de gaucher.
MX2010006933A (es) Composiciones y metodos para reducir o prevenir la deshidratación de la piel.
MY155564A (en) Arginine salts and their uses for the treatment of illnesses in the oral cavity
EP2569330A4 (en) CHLOROTOXIN VARIANTS AND CONJUGATES AND METHOD OF USE THEREOF
MX2010003013A (es) Inhibicion de angiogenesis.
WO2010009127A3 (en) Tooth whitening compositions and methods
IN2014DN07483A (el)
MX342947B (es) Tratamiento de diabetes tipo 2.
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
GR1006881B (el) Αντιγηραντικες ιδιοτητες της κερκετινης, του 18(α) - γλυκυρετινικου οξεος της χεδεραγενινης και των παραγωγων τους
ZA201008160B (en) Compositions for the treatment of hair loss
DOP2012000156A (es) Nuevos derivados de (heterociclo-piperidina condensada)-(piperazini)-1-alcanona o de (heterociclo-pirrolidina condensada)-(piperazinil)-1-alcanona y su utilizacion como inhibidores de p75
UA110332C2 (en) Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea
MX339361B (es) Derivados de alternano.
DOP2012000146A (es) Nuevos derivados (heterociclo-tetrahidro-piridin)-(piperazinil)-1-alcanona y (heterociclo-dihidro-pirrolidin)-(piperazinil)-1-alcanona y su utilizacion como inhibidores de p75
WO2012013417A3 (en) Skin care compositions comprising substituted diamines

Legal Events

Date Code Title Description
PG Patent granted
MF Right revoked (revocation)

Effective date: 20121113

ML Lapse due to non-payment of fees

Effective date: 20121102

NF Restoration of lapsed right

Effective date: 20130122